Anthropic sent and then retracted IPO documents that showed plans to raise $69.3 billion. The firm told bankers the details were inaccurate after sharing a target of 867 million shares. Investors now watch for a downsized valuation as the company prepares to market its upcoming IPO with JPMorgan and others.
IPO-bound Anthropic PBC first sent out, and then retracted a filing that showed that it planned on raising as much as $69.3 billion through its Initial Public Offering (IPO), according to a Reuters report.
Anthropic first sent bankers a copy of the IPO target, which showed that it planned on selling as many as 867 million shares in the price range of $70 to $80 per share, but soon after sent a follow-up email, saying that those details are inaccurate, according to the Reuters report.
According to another report in The Information, the retracted filing was an updated prospectus sent by Anthropic's counsel outside in Canada. The counsel later told bankers that some of the details in the filing were inaccurate and that the filing would be updated later.
The IPO comes at a time when the midterm election results have raised questions on the future of the AI buildout story after the democrats swept the elections, resulting in trillions getting wiped out from tech stocks in the aftermath, before a rebound on Monday.
Potential investors of Anthropic are now looking at a downsized valuation of $1.1 trillion to $1.3 trillion, down from the $2 trillion reported earlier last month.
Anthropic is planning a live-streamed event to market its IPO along with its Co-founder and CEO Dario Amodei and JPMorgan's CEO Jamie Dimon, according to a Bloomberg report. The report further stated that the marketing will begin as early as Tuesday.
JPMorgan is one of the 22 banks working on the Anthropic IPO, and is leading the domestic retail marketing and share allocations. Retail investors could have 15% to 20% of the total shares reserved for the IPO, as per reports.
Goldman Sachs has the lead-left role on the IPO, while Morgan Stanley is acting as stabilization agent, according to Anthropic’s filing with the US Securities and Exchange Commission.